CMS prior-authorization proposal could reshape drug approvals

CMS has proposed a major update to how some health plans handle drug prior authorizations. The agency says the goal is to make the process faster, more transparent, and less burdensome for patients and clinicians.

If the rule is finalized, the changes would affect several federally regulated plan types, including Medicare Advantage, Medicaid and CHIP managed care, and ACA Marketplace plans sold on the federal exchange. CMS also proposed adding small-group federal exchange plans to the group of affected payers. But even then, the exact experience for a patient would still depend on the plan, the state, and whether the drug is covered under a medical or pharmacy benefit.

What CMS proposed on April 10, 2026

In a fact sheet released April 10, 2026, CMS said it wants to extend earlier interoperability and prior-authorization policies to cover drugs. The proposal would require affected payers to support electronic prior authorization for drugs and to use newer data standards so providers can send and track requests through connected systems rather than relying so heavily on portals, faxes, and manual paperwork.

The agency also proposed new reporting requirements for payer API endpoints and related technical information. CMS says those changes would make interoperability tools easier to find and use.

Which payers would be affected

CMS said the proposal would apply to the same broad group of impacted payers already covered by prior interoperability rules: Medicare Advantage organizations, state Medicaid fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers on the federally facilitated exchanges. CMS also proposed adding small-group market QHP issuers on the Federally-facilitated Small Business Health Options Program.

That matters because many readers encounter prior authorization through employer coverage, Marketplace plans, or public programs like Medicaid rather than through one national system.

What would change for drug prior authorization

CMS proposed that affected payers support electronic prior authorization for drugs covered under a medical benefit beginning October 1, 2027. For drugs covered under a pharmacy benefit, the proposal would require support for specific NCPDP standards used to exchange formulary, benefit, and real-time prescription information and to submit prior-authorization requests electronically.

CMS also proposed tighter response windows. In general, the agency wants drug prior-authorization decisions to line up more closely across programs, with standards that could require decisions within 24 hours in some Medicaid and CHIP settings and within 72 hours or 24 hours for certain Marketplace requests, depending on whether the request is standard or expedited.

What the timelines are

The proposal was released April 10, 2026, and CMS says the public comment period runs through June 15, 2026. The agency’s fact sheet says compliance dates would begin October 1, 2027 for the drug-related decision-timeframe proposals and related electronic prior-authorization standards. CMS also says some HIPAA-covered entities would have 24 months after a final rule’s effective date to comply, while small health plans would get 36 months.

CMS’s electronic prior-authorization overview also says certain health plans regulated by CMS are expected to begin implementing APIs starting January 1, 2027, showing that the agency is already preparing the broader workflow shift even before this drug proposal is finalized.

Why patients may still see variation

Even if CMS finalizes the rule, patients should not expect one uniform experience. Prior authorization still varies by benefit design, state rules, payer contracts, provider systems, and whether a drug is billed under a medical benefit or a pharmacy benefit. Some plans and providers may be ready to move faster than others, and some electronic workflows may roll out unevenly.

CMS’s broader policy pages also show that the agency is building this work on top of earlier interoperability and prior-authorization rules, rather than replacing the entire system at once.

What the evidence and policy context suggest

CMS says the current process can create unnecessary delays and administrative burden, and its policy pages frame electronic prior authorization as a way to reduce paper-heavy workflows, improve transparency, and speed decisions. The agency’s broader 2026 materials also show it is already pushing health plans and vendors toward standardized APIs and electronic requests beginning in 2027.

That does not mean prior authorization would disappear. It does mean more requests could move into electronic systems with clearer standards and deadlines, which may matter most for patients who regularly need medications approved or renewed.

What readers can watch next

This proposal is still under review, so the biggest near-term step is to watch for CMS’s final rule and any implementation guidance that follows. If you have insurance, it is reasonable to ask your plan or provider’s office how prior authorization is handled for your drug benefit, whether requests are submitted electronically, and how long decisions usually take.

For people in Medicare Advantage, Medicaid, CHIP, or the ACA Marketplace, the most important takeaway is that this proposal is not final yet. If finalized, it could make drug approvals more predictable and less paper-heavy for many patients and clinicians.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.